The Committee for Medicinal Products for Human Use recommends marketing approval for Merck's Keytruda for treating two types of gynecologic cancers.

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of MSD’s ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S.Food and Drug Administration (FDA) ...

Few companies have attracted more attention this year than Nvidia. The chipmaker is on a roll thanks to the rapid rise of ...

Bob Duggan’s success shows you don’t need a Ph.D., or even a college education, to make money in the complex world of biotech ...

EU CHMP recommends approval of Merck’s Keytruda regimens as treatment for patients with two types of gynaecologic cancers ...

Peter Milios is a recent graduate from the University of Technology - majoring in Finance and Accounting. Peter is currently ...

Discover why PDS Biotechnology's HPV-directed immunotherapy is sparking optimism in the biotech industry, despite typical ...

Roading aside, work has been ongoing in Government to tackle some of the issues that Tararua District residents tell me are ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Merck & Company (MRK – Research Report), ...

The programme is an extension of the US Cancer Moonshot initiative started in 2016. It aims to strengthen the overall cancer ...